JAZZPDUFA
Ziihera® (zanidatamab-hrii) + chemo
HER2-positive gastroesophageal adenocarcinoma (GEA)
Approval decisionClinical and regulatory intelligence
Review the next 14 days of clinical data readouts, commercial milestones and regulatory decisions. Advanced search, monitoring and the complete timeline are reserved for Pro.
Public preview
HER2-positive gastroesophageal adenocarcinoma (GEA)
Approval decisionUse this 14-day public preview to discover upcoming biotech catalyst dates across clinical, commercial and regulatory event types. Advanced monitoring remains reserved for Pro subscribers.
Human Immunodeficiency Virus
Approval decisionDiabetic cardiomyopathy, Transthyretin amyloidosis, Transthyretin Amyloid Cardiomyopathy
Data readoutCancer, Gastroesophageal adenocarcinomas, Cholangiocarcinoma
Data readout